M4MM
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
